Raphael Pharmaceutical RAPH
OTC RAPH
$1.40 +0.00 (+0.00%)
At close: Aug 18, 2026 · 4:00 PM EDT

Raphael Pharmaceutical (RAPH) Return on Capital Employed (QoQ) (2022 - 2024)

Raphael Pharmaceutical (RAPH) Return on Capital Employed (QoQ) (2022 - 2024) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 43.83 Bn 42.86 Bn -
2 Teva Pharmaceutical Industries 42.87 Bn 39.22 Bn 2.15 Bn
3 Zoetis 31.41 Bn 29.73 Bn 1.05 Bn
4 Takeda Pharmaceutical 28.55 Bn 22.75 Bn 5.10 Bn
5 United Therapeutics 22.08 Bn 19.42 Bn 683.80 Mn
6 Viatris 18.73 Bn 17.84 Bn 1.46 Bn
7 Neurocrine Biosciences 15.44 Bn 15.05 Bn 935.80 Mn
8 Elanco Animal Health 11.75 Bn 11.22 Bn 798.00 Mn
9 Dr Reddys Laboratories 10.11 Bn 9.94 Bn -
10 Raphael Pharmaceutical 28.25 Mn 28.25 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2024 3,684.00
Sep 30, 2024 -61,379.00
Jun 30, 2024 -19,196.00
Mar 31, 2024 164,864.00
Dec 31, 2023 -182,970.00
Sep 30, 2023 -589,167.00
Jun 30, 2023 1.12 Mn
Sep 30, 2022 1.30 Mn
Jun 30, 2022 -92,442.00
Mar 31, 2022 -382,555.00